A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
- Can Paroxetine Increase Creatine Kinase. Yenilmez, Dicle; Atagun, Murat Ilhan; Suleyman Can, Serdar; Caykoylu, Ali // Journal of Mood Disorders;2014, Vol. 4 Issue 2, p91
A letter to the editor about the use of paroxetine in the treatment of anxiety and depressive disorders is presented.
- Relieving burden posed by anxiety. Cocdyre, David // New Zealand Doctor;11/4/2009, p20
The article presents a medical case of a Samoan man with panic attacks. He was diagnosed with panic disorder and treated with paroxetine. He was followed up to monitor his progress and was referred to a local cognitive-behavioral therapy (CBT) provider to assist him with psychoeducation with...
- Editor's Message. Issue Highlights, October 2011. Kalali, Amir // Innovations in Clinical Neuroscience;Oct2011, Vol. 8 Issue 10, p3
An introduction is presented in which the editor discusses various reports within the issue on the treatment of bipolar disorder by primary care physicians, an update on cognition, and an in-depth review of delirium.
- Otizm ve ZekÃ¢ GeriliÄŸi olan Bir Ergende Uygunsuz Cinsel DavranÄ±ÅŸlar iÃ§in Risperidone ve Paroxetine Birlikte KullanÄ±mÄ±. HERGÜNER, Sabri; HERGÜNER, Arzu; ÇİÇEK, Erdinç // Archives of Neuropsychiatry / Noropsikiatri Arsivi;Dec2012, Vol. 49 Issue 4, p311
Inappropriate hypersexual behaviors have been frequently reported in subjects with autism, however, literature on management of such behaviors in this group is very limited. In this paper, we describe an adolescent with autistic disorder and mental retardation who developed severe inappropriate...
- NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Ghasemi, Mehdi; Montaser-Kouhsari, Laleh; Shafaroodi, Hamed; Nezami, Behtash Ghazi; Ebrahimi, Farzad; Dehpour, Ahmad Reza // Psychopharmacology;Oct2009, Vol. 206 Issue 2, p325
In this study, we evaluated the involvement of N-methyl- d-aspartate receptor (NMDAR)/nitric oxide (NO) system on the antidepressant-like effects of paroxetine in the mouse forced swimming test. Swim sessions were conducted by placing mice in individual glass cylinders filled with water for 6...
- Sustained stress-induced changes in mice as a model for chronic depression. Elizalde, Natalia; García-García, Alvaro L.; Totterdell, Susan; Gendive, Nerea; Venzala, Elisabet; Ramirez, Maria J.; Del Rio, Joaquin; Tordera, Rosa M. // Psychopharmacology;Jul2010, Vol. 210 Issue 3, p393
Major depression is a chronic disabling disorder, often preceded by stress. Despite emerging clinical interest in mechanisms perpetuating episodes of depression and/or establishing increased vulnerability for relapse, little attention has been paid to address these aspects in experimental...
- Treating the Modern Malaise. // Hedgehog Review;Fall2015, Vol. 17 Issue 3, p15
The article offers information on several drugs for depression. Topics covered include the launch of serax as an anti-anxiety treatment in the 1960s as well as the use of Paxil to treat patients suffering from depression. Also mentioned is the application of Straterra to help people who are...
- Clinical digest. Claims for safety and efficacy of paroxetine in teens with depression were 'misleading'. // Nursing Standard;9/30/2015, Vol. 30 Issue 5, p15
The article discusses research which investigated efficacy and safety of paroxetine and imipramine in treating adolescent patients with major depression, conducted by J. Le Noury and colleagues, published in a 2015 issue of "The BMJ" journal.
- Paroxetine. // AHFS Consumer Medication Information;Feb2017, p1
Paroxetine tablets, suspension (liquid), and extended-release (long-acting) tablets are used to treat depression, panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks), and social anxiety disorder (extreme fear of interacting with others or performing in front...